paul rhodes

Paul Rhodes is the CEO and Founder of Next Gen Diagnostics, a company focused on bringing whole genome sequencing to clinical microbiology.1 He has an extensive background in science and entrepreneurship:

Education

Paul Rhodes holds degrees from prestigious institutions:

• AB in Physics (Magna cum Laude) from Harvard University
• Master of Science in Physics from Stanford University
• PhD in Neuroscience from NYU Medical School1

Professional Experience

Next Gen Diagnostics

As CEO and Founder since 2017, Rhodes leads Next Gen Diagnostics in developing low-cost, fully integrated pathogen sequencing and bioinformatics services.1 The company aims to enable hospital transmission detection and sequence-based infection diagnostics.1

Previous Ventures

Prior to Next Gen Diagnostics, Rhodes founded and led other innovative companies:

• Specific Diagnostics (2011-2022): Developed a rapid antibiotic susceptibility system using novel sensor technology.1
• Evolved Machines (2005-2012): Pioneered simulations of large-scale neural circuitry that self-organizes during sensory input.1

Expertise and Contributions

Rhodes brings extensive expertise in microbiology diagnostics, genomics, physics, and neuroscience to his role at Next Gen Diagnostics.45 Under his leadership, the company has:

• Established world-leading automation of pathogen bioinformatics2
• Developed validated systems for bacterial resistance determination from whole genome sequencing2
• Formed partnerships and subsidiaries in the US, UK, and Israel to advance clinical applications of pathogen sequencing23

Rhodes is actively involved in expanding Next Gen Diagnostics' reach and capabilities, as evidenced by recent announcements of new advisory board members and international expansions.23